|
 |
|
| Home > In Vitro Diagnostics |
| |
| |
|
| |
 In Vitro Diagnostics Market Research Reports |
World Thrombin Time Testing Market: Country Forecasts, Innovative Technologies, Competitive Strategies--France, Germany, Italy, Japan, Spain, UK, USA
The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next five years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation....
|
 |
|
$4350.00 |
| |
|
|
|
Thermo Fisher: Diagnostics Sales, Market Shares and Competitive Position by Product and Country
This unique market intelligence report from Venture Planning Group provides information not available from any other published source. The report includes diagnostics sales and market share estimates by product and country for Thermo Fisher and its main competitors, as well as a profile of the company�s diagnostics business.
|
|
|
$4250.00 |
| |
|
|
|
2016 Australia Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.
|
|
|
$4250.00 |
| |
|
|
|
2016 Austria Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.
|
|
|
$4250.00 |
| |
|
|
|
2016 Belgium Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.
|
|
|
$4250.00 |
| |
|
|
|
2016 Bulgaria Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.
|
|
|
$4250.00 |
| |
|
|
|
2016 Canada Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.
|
|
|
$4250.00 |
| |
|
|
|
2016 Cyprus Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.
|
|
|
$4250.00 |
| |
|
|
|
2016 Czech Republic Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.
|
|
|
$4250.00 |
| |
|
|
|
2016 Denmark Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.
|
|
|
$4250.00 |
| |
|
|
|
2016 Estonia Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.
|
|
|
$4250.00 |
| |
|
|
|
2016 Finland Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.
|
|
|
$4250.00 |
| |
|
|
|
2016 Greece Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.
|
|
|
$4250.00 |
| |
|
|
|
2016 Hungary Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.
|
|
|
$4250.00 |
| |
|
|
|
2016 Iceland Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.
|
|
|
$4250.00 |
| |
|
|
|
2016 Ireland Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.
|
|
|
$4250.00 |
| |
|
|
|
2016 Latvia Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.
|
|
|
$4250.00 |
| |
|
|
|
2016 Lithuania Nucleic Acid Testing (NAT) Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities
This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.
|
|
|
$4250.00 |
| |
|
|
|
|